Page 2 - Nasdaq Beam News Today

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) rose 7.3% on Monday . The stock traded as high as $25.46 and last traded at $25.43. Approximately 103,262 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 877,630 shares. The stock had previously closed at $23.69. Analysts […]

Wedbush reaffirmed their outperform rating on shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) in a report issued on Monday morning, RTT News reports. The brokerage currently has a $48.00 target price on the stock. BEAM has been the topic of several other research reports. Leerink Partnrs lowered Beam Therapeutics from an outperform rating to […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) insider Christine Bellon sold 1,907 shares of the business’s stock in a transaction that occurred on Wednesday, January 3rd. The stock was sold at an average price of $26.42, for a total value of $50,382.94. Following the sale, the insider now owns 80,495 shares of the company’s […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) insider Christine Bellon sold 1,907 shares of the business’s stock in a transaction that occurred on Wednesday, January 3rd. The shares were sold at an average price of $26.42, for a total transaction of $50,382.94. Following the transaction, the insider now owns 80,495 shares of the company’s […]

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) saw an uptick in trading volume on Wednesday . 412,813 shares were traded during mid-day trading, a decline of 59% from the previous session’s volume of 1,014,700 shares.The stock last traded at $30.42 and had previously closed at $29.82. Analysts Set New Price Targets Several […]

ARK Investment Management LLC raised its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 4.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,783,891 shares of the company’s stock after acquiring an additional 401,296 shares during the […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $28.75, but opened at $27.49. Beam Therapeutics shares last traded at $27.45, with a volume of 241,061 shares. Wall Street Analyst Weigh In BEAM has been the subject of several recent analyst […]

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have received a consensus recommendation of “Hold” from the eleven ratings firms that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned an average rating of “Hold” from the eleven analysts that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price target […]

Wedbush reissued their outperform rating on shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) in a research note released on Monday morning, RTT News reports. They currently have a $48.00 target price on the stock. Wedbush also issued estimates for Beam Therapeutics’ FY2024 earnings at ($4.32) EPS, FY2025 earnings at ($4.65) EPS, FY2026 earnings at […]